Tag Archives: NASDAQ:VIGL

Collaborating with Patient Advocacy Groups to Advance Rare Disease Awareness and Support
March 29, 2022

By Ivana Magovčević-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC Over my many years in the biopharma industry, working across disease areas, including orphan indications, I have learned that to impact patients’ lives

Leave a comment